Whereas a slight increase of CD20 alternative splicing was detected in CBCL, LZM, MM, and some CLL samples, a significantly higher amount of alternative transcripts was observed in FL, HG-NHL, and EBV-transformed B cell lines. The gene discussed is MS4A1; the disease is non-Hodgkin lymphoma.